$FRMM 8-K/A SEC Filings

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURIT...

On August 8, 2025, ETHZilla Corporation formerly 180 Life Sciences Corp. (the “Company”, “we” and “us”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with investment funds managed by an institutional ...

As previously disclosed in the Current Report on Form 8-K of ETHZilla Corporation, formerly 180 Life Sciences Corp. (the “Company”), filed with the Securities and Exchange Commission (the “SEC” or the “Commission”) on July 30, 2025 (the ...

On June 12, 2025, Mr. Jay Goodman resigned as a member of the Board of Directors, of 180 Life Sciences Corp. (the “Company”, “we” and “us”), effective on June 13, 2025, and entered into a Release Agreement with the Company dated June 12,...

The information and disclosure in Item 5.01 below regarding the voting rights of the Series B Convertible Preferred Stock is incorporated by reference into this Item 3.03.

The information and disclosure in Item 5.01 below regarding the voting rights of the Series B Convertible Preferred Stock is incorporated by reference into this Item 3.03.